New Jersey Attorney General Matthew J. Platkin and the attorneys general of California, Massachusetts, and New York filed a petition requesting that the U.S. Food and Drug Administration (FDA) eliminate unnecessary restrictions on the abortion medication mifepristone. “We will never waver in our support for reproductive freedom, and we will not stand by while the Trump Administration threatens access to essential reproductive health care.  Access to mifepristone saves lives and is critical for reproductive choice.  That’s why we will continue to fight to ensure that New Jerseyans can continue to access mifepristone. Federal restrictions on mifepristone are burdensome impediments to reproductive choice and are not based in science or medicine. The FDA has an opportunity to do the right thing and to eliminate barriers to access to this critical medication. I am proud to file this petition and to call on the FDA to make mifepristone more accessible for women across the country.” – AG Platkin